Victor K. Phuong

Discovery of the first known small-molecule inhibitors of heme-regulated eukaryotic initiation factor 2alpha (HRI) kinase.

M. Rosen, C. Woods, S. Goldberg, 2009, Bioorganic & medicinal chemistry letters.

Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX(2)R) antagonists.

C. Dvorak, T. Lovenberg, N. Carruthers, 2004, Bioorganic & medicinal chemistry letters.

Discovery of potent cholecystokinin-2 receptor antagonists: elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysis.

Jiejun Wu, C. Schubert, M. Rosen, 2008, Bioorganic & medicinal chemistry.

Identification and optimization of anthranilic sulfonamides as novel, selective cholecystokinin-2 receptor antagonists.

M. Rosen, C. Woods, M. Hack, 2006, Journal of medicinal chemistry.

Novel Substituted 4‐Phenyl‐[1,3]dioxanes: Potent and Selective Orexin Receptor 2 (OX2R) Antagonists.

C. Dvorak, T. Lovenberg, N. Carruthers, 2004 .

Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists I: discovery of CCKR1 selectivity in a previously CCKR2-selective lead series.

Victor K. Phuong, N. Shankley, Marna Pippel, 2009, Bioorganic & medicinal chemistry letters.